Next report date
Report period
Q1 2024
EPS estimate
—
Revenue estimate
—
139.27 MUSD
1.15 BUSD
194.74 M
Om TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED
Sektor
Bransch
VD
Lei Wang
Webbplats
Huvudkvarter
Tianjin
Employees (FY)
4.62 K
Grundat
1981
ISIN
CNE100000924
FIGI
BBG000BH6J65
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
